Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adefovir dipivoxil in children with interferon-unresponsive, lamivudine-resistant chronic hepatitis B
ChiCTR-ONRC-12001924Phase 4Completed
- Sponsor
- The Second Hospital of Nanjing
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of adefovir dipivoxil in Chronic Hepatitis B (CHB), sponsored by The Second Hospital of Nanjing. Primary endpoints: Hepatitis B serologic markers, HBV DNA and 3 more. Started Jan 2006; status: completed.
02
Drugs
adefovir dipivoxil
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-ONRC-12001924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONRC-12001924.